HOLLY MILLER: Open Payments
NPI 1053492686 · MARIETTA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$772 in 33 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $650 · 2025 $772
Food & beverage: $772
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $147 |
| Biogen, Inc. | 8 | $143 |
| UCB, Inc. | 5 | $135 |
| Eisai Inc. | 5 | $126 |
| Neurocrine BioSciences, Inc. | 3 | $66 |
| Novartis Pharmaceuticals Corporation | 2 | $54 |
| Lilly USA, LLC | 1 | $31 |
| SK Life Science, Inc. | 1 | $24 |
| Merz Pharmaceuticals, LLC | 1 | $23 |
| Lundbeck LLC | 1 | $23 |
Products named: Briviact, TYSABRI, Leqembi, INGREZZA, BOTOX, UBRELVY, KESIMPTA, KISUNLA.
Industry payments across OH — which companies pay providers there.
